Feature | September 04, 2014 | Greg Freiherr

Tomo Draws the Line In Breast Screening

Intelerad

Westerners want neatly drawn lines, simple demarcations, absolutes. In some cases, the lines are apparent. Others are not. Continents are easy to distinguish visibly from oceans. The boundaries between countries are not.

If drawing such differences depends on physical evidence, shouldn’t a clear distinction be possible between diseased and healthy tissue? This paradox is obvious when screening for breast cancer. Improving the means for seeing early signs should do the trick. Breast tomosynthesis may be it.

On June 25, JAMA (Journal of the American Medical Association) published research indicating that the addition of 3-D imaging — breast tomosynthesis — to mammography results in the discovery of more cancers than the use of 2-D digital mammography alone — a 41 percent increase in the detection of invasive breast cancers and a 29 percent increase in the detection of all breast cancers.

The data is hardly surprising. The U.S. Food and Drug Administration (FDA) approved the sale of tomo devices for breast cancer screening in 2011 because of similar research findings. The JAMA paper underscores this, while shining a light on one of the most appealing side benefits — a reduction in false positives and consequent reduction of recall rates. Before the publication of this paper, this positive effect had been largely anecdotal.

Data acquired at 13 U.S. centers performing 454,850 screening exams (61 percent of which involved only 2-D digital mammography for comparison) found that the addition of tomo dropped the recall rate from 107 to 91 per 1,000 screening exams — a 15 percent decrease. This translates to 16 fewer recalls per 1,000 screening exams. 

Callbacks have always been a problem in mammography. They are a source of worry, added discomfort, patient complaints and unnecessary cost. Moreover, they call into question the credibility of exams, whose use depends on women’s belief in their value.

The new study addresses this concern and another often attributed to breast cancer screening — the finding of cancers that don’t need to be treated. The latter was demonstrated by the 41 percent increase in the detection of invasive breast cancers; the former by a double-digit reduction in the recall rate. 

It’s hard to overestimate the importance of these findings. Screening mammography exposes women with no known sign of disease to ionizing radiation, which itself can cause cancer. As such, women deserve the greatest possible assurance that the exam they undergo is done with the least chance of being wrong.

The JAMA study documents that the routine use of tomosynthesis in breast cancer screening does exactly this, providing women the reason to believe that modern mammography truly can save lives. 

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
Breast Cancer Places Greater Financial Burden on Black Women
News | Women's Health | May 16, 2018
Having breast cancer placed a significantly greater financial strain on black women than white women, according to a...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Overlay Init